Determination of factors predictive of outcome for patients undergoing a pancreaticoduodenectomy of pancreatic head ductal adenocarcinomas

HPB

Volumn 14, Issue 5, 2012, Pages 310-316

  Eeson, Gareth ^a   Chang, Nicolas ^a   McGahan, Colleen E ^b   Khurshed, Fareeza ^b   Buczkowski, Andrzej K ^a   Scudamore, Charles H ^a   Warnock, Garth L ^a   Chung, Stephen W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

pancreatic neoplasia; pancreaticoduodenectomy; resection < pancreatic neoplasia; Whipple resection

Indexed keywords

AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREATIC HEAD DUCTAL ADENOCARCINOMA; PANCREATICODUODENECTOMY; PREDICTION; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 84859715249     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2012.00448.x     Document Type: Article

References (24)

1. Jemal A, Siegel R, Xu J, Ward E,. (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
2. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R,. (2009) EUROCARE-4: survival of cancer patients diagnosed in 1995-1999: results and commentary. Eur J Cancer 45: 931-991.
3. Batidas JA, Poen JC, Niederhuber JE,. (2000) Pancreas. In:, Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE, eds. Clinical Oncology, 2nd edn. Philadelphia, PA: Churchill-Livingston, pp. 1749-1783.
4. Cleary SP, Gryfe R, Guindi M, Greig P, Smith L, Mackenzie R, et al,. (2004) Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg 198: 722-731. (Pubitemid 38542900)
5. Stojadinovic A, Brooks A, Hoos A, Jaques DP, Conlon KC, Brennan MF,. (2003) An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma. J Am Coll Surg 196: 954-964. (Pubitemid 36676558)
6. Neoptolemos JP, Cunningham D, Friess H, Bassi C, Stocken DD, Tait DM, et al,. (2003) Adjuvant therapy in pancreatic cancer: historical and current perspectives. Ann Oncol 14: 675-692. (Pubitemid 36621766)
7. Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, et al,., for the Groupe Tumeurs Digestives of Unicancer and the PRODIGE Intergroup. (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364: 1817-1825.
8. Finks JF, Osborne NH, Birkmeyer JD,. (2011) Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med 364: 2128-2137.
9. Cameron JL, Riall TS, Coleman J, Belcher KA,. (2006) One thousand consecutive pancreaticoduodenectomies. Ann Surg 244: 10-15. (Pubitemid 44297442)
10. Dindo D, Demartines N, Clavien P-A,. (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240: 205-213. (Pubitemid 38963009)
11. Sobin LH, Gospodarowicz MK, Wittekind C, eds. (2009) TNM Classification of Malignant Tumors, 7th edn. Wiley-Blackwell: Oxford.
12. Garden OJ,. (1997) Liver and pancreatic resection in the elderly. HPB Surg 10: 259-261.
13. Louis DJ, Hsu A, Brand MI, Saclarides TJ,. (2009) Morbidity and mortality in octogenarians and older undergoing major intestinal surgery. Dis Colon Rectum 52: 59-63.
14. de Haas RJ, Wicherts DA, Andreani P, Pascal G, Saliba F, Ichai P, et al,. (2011) Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resection. Ann Surg 253: 1069-1079.
15. Schwartz RS,. (2001) Immunodeficiency, immunosuppression, and susceptibility to neoplasms. J Natl Cancer Inst 28: 5-9.
16. Kressner U, Graf W, Mahteme H, Pahlman L, Glimelius B,. (2002) Septic complications and prognosis after surgery for rectal cancer. Dis Colon Rectum 45: 316-321. (Pubitemid 34273609)
17. Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, et al,. (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346: 1128-1137. (Pubitemid 34984604)
18. Birkmeyer JD, Sun Y, Wong SL, Stukel TA,. (2007) Hospital volume and late survival after cancer surgery. Ann Surg 245: 777-783. (Pubitemid 46684108)
19. Topal B, Van de Sande S, Fieuws S, Penninckx F,. (2007) Effect of centralization of pancreaticoduodenectomy on nationwide hospital mortality and length of stay. Br J Surg 94: 1377-1381. (Pubitemid 350144386)
20. Lall CG, Howard TJ, Skandarajah A, DeWitt JM, Aisen AM, Sandrasegaran K,. (2007) New concepts in staging and treatment of locally advanced pancreatic head cancer. AJR Am J Roentgenol 189: 1044-1050. (Pubitemid 350032986)
21. Varadhachary GR, Tamm EP, Abbruzzese JL, Xiong HQ, Crane CH, Wang H, et al,. (2006) Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 13: 1035-1046. (Pubitemid 44337962)
22. Langer B,. (2007) Role of volume outcome data in assuring quality in HPB surgery. HPB (Oxford) 9: 330-334. (Pubitemid 47604631)
23. van Heek NT, Kuhlmann KF, Scholten RJ, de Castro SM, Busch OR, van Gulik TM, et al,. (2005) Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands. Ann Surg 242: 781-788.
24. Fennell ML, Das IP, Clauser S, Petrelli N, Salner A,. (2010) The organization of multidisciplinary care teams: modeling internal and external influences on cancer care quality. J Natl Cancer Inst Monogr 2010: 72-80.